Tracing goes viral: Viruses that introduce expression of fluorescent proteins in chemically-specific neurons
暂无分享,去创建一个
Antonio Luchicchi | Tommy Pattij | Nathan Marchant | A. Luchicchi | T. Pattij | Nathan J. Marchant | S. D. de Kloet | J. N. Viaña | Sybren F. de Kloet
[1] Kimberly R. Clark,et al. Physiological Properties of Hypothalamic MCH Neurons Identified with Selective Expression of Reporter Gene after Recombinant Virus Infection , 2004, Neuron.
[2] T. Hökfelt,et al. Hypothalamic CNTF volume transmission shapes cortical noradrenergic excitability upon acute stress , 2018, The EMBO journal.
[3] P. Malik,et al. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors , 2007, Gene Therapy.
[4] P. Lowenstein,et al. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] B. Sabatini,et al. Corelease of acetylcholine and GABA from cholinergic forebrain neurons , 2015, eLife.
[6] D. L. Haggerty,et al. Adeno-Associated Viral Vectors in Neuroscience Research , 2019, Molecular therapy. Methods & clinical development.
[7] G. Gao,et al. Adeno-associated virus vector as a platform for gene therapy delivery , 2019, Nature Reviews Drug Discovery.
[8] Kenneth P Vives,et al. Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] S. Tonegawa,et al. Creating a False Memory in the Hippocampus , 2013, Science.
[10] Liqun Luo,et al. Viral-genetic tracing of the input–output organization of a central norepinephrine circuit , 2015, Nature.
[11] A. Bahi,et al. Selective lentiviral-mediated suppression of microRNA124a in the hippocampus evokes antidepressants-like effects in rats , 2014, Psychoneuroendocrinology.
[12] Michael L. Wallace,et al. Multi-transmitter neurons in the mammalian central nervous system , 2017, Current Opinion in Neurobiology.
[13] Samuel D. Gale,et al. Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[14] C. J. Lee,et al. AAV-Mediated Astrocyte-Specific Gene Expression under Human ALDH1L1 Promoter in Mouse Thalamus , 2017, Experimental neurobiology.
[15] S. Kügler,et al. Promoters and serotypes: targeting of adeno‐associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo , 2005, Experimental physiology.
[16] K. Deisseroth. Optogenetics: 10 years of microbial opsins in neuroscience , 2015, Nature Neuroscience.
[17] K. Bankiewicz,et al. Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. , 2013, Human gene therapy.
[18] Steven J. M. Jones,et al. rAAV-compatible MiniPromoters for restricted expression in the brain and eye , 2016, Molecular Brain.
[19] M. Sommer,et al. Transduction of Craniofacial Motoneurons Following Intramuscular Injections of Canine Adenovirus Type-2 (CAV-2) in Rhesus Macaques , 2019, Front. Neuroanat..
[20] J. Neumaier,et al. DREADDing the lateral habenula: A review of methodological approaches for studying lateral habenula function , 2013, Brain Research.
[21] D. Metzger,et al. Engineering the mouse genome by site-specific recombination. , 1999, Current opinion in biotechnology.
[22] Allan R. Jones,et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.
[23] Zhijian Wu,et al. Effect of genome size on AAV vector packaging. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[24] B. Nilius. Pflügers Archiv and the advent of modern electrophysiology , 2003, Pflügers Archiv.
[25] Z. Ahmed,et al. AAV8 gfp preferentially targets large diameter dorsal root ganglion neurones after both intra-dorsal root ganglion and intrathecal injection , 2012, Molecular and Cellular Neuroscience.
[26] K. Deisseroth,et al. A fourth generation of neuroanatomical tracing techniques: Exploiting the offspring of genetic engineering , 2014, Journal of Neuroscience Methods.
[27] C. Harms,et al. Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice , 2016, Molecular and Cellular Neuroscience.
[28] W. Stanford,et al. The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[29] Benjamin F. Grewe,et al. Distinct Hippocampal Pathways Mediate Dissociable Roles of Context in Memory Retrieval , 2016, Cell.
[30] Akinori Akaike,et al. Multiplex Neural Circuit Tracing With G-Deleted Rabies Viral Vectors , 2020, Frontiers in Neural Circuits.
[31] N. Martin,et al. Recombinant Viral Vectors as Neuroscience Tools , 2019, Current protocols in neuroscience.
[32] D. Cliver. Capsid and Infectivity in Virus Detection , 2009, Food and Environmental Virology.
[33] E. Kremer,et al. CAV-2--why a canine virus is a neurobiologist's best friend. , 2015, Current opinion in pharmacology.
[34] Susumu Tonegawa,et al. Inception of a false memory by optogenetic manipulation of a hippocampal memory engram , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[35] B. Casto,et al. Adenovirus-Associated Defective Virus Particles , 1965, Science.
[36] Dae-Shik Kim,et al. Global and local fMRI signals driven by neurons defined optogenetically by type and wiring , 2010, Nature.
[37] M. Klugmann,et al. Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model , 2017, Brain : a journal of neurology.
[38] B. A. French,et al. Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery , 2013, Gene Therapy.
[39] Michael Brenner,et al. GFAP promoter elements required for region‐specific and astrocyte‐specific expression , 2008, Glia.
[40] H. Mansvelder,et al. Illuminating the role of cholinergic signaling in circuits of attention and emotionally salient behaviors , 2014, Front. Synaptic Neurosci..
[41] Charles R. Gerfen,et al. Targeting Cre Recombinase to Specific Neuron Populations with Bacterial Artificial Chromosome Constructs , 2007, The Journal of Neuroscience.
[42] Ian R. Wickersham,et al. Retrograde neuronal tracing with a deletion-mutant rabies virus , 2007, Nature Methods.
[43] I. Martins,et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] Shingo Tanaka,et al. Double Virus Vector Infection to the Prefrontal Network of the Macaque Brain , 2015, PloS one.
[45] M. Ehlers,et al. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. , 2011, Human gene therapy.
[46] Edward M Callaway,et al. Improved Monosynaptic Neural Circuit Tracing Using Engineered Rabies Virus Glycoproteins. , 2016, Cell reports.
[47] Sripriya Ravindra Kumar,et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain , 2015, Nature Biotechnology.
[48] B. Hyman,et al. Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65 , 2018, Molecular therapy. Methods & clinical development.
[49] Elyssa B. Margolis,et al. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour , 2017, Nature Reviews Neuroscience.
[50] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[51] J. Muir,et al. Excitotoxic lesions of basal forebrain cholinergic neurons: Effects on learning, memory and attention , 1993, Behavioural Brain Research.
[52] Lynne,et al. Site-specific integration by adeno-associated virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[53] Ian R. Wickersham,et al. Monosynaptic circuit tracing in vivo through Cre-dependent targeting and complementation of modified rabies virus , 2010, Proceedings of the National Academy of Sciences.
[54] Janine L Kwapis,et al. A neuroscientist’s guide to transgenic mice and other genetic tools , 2019, Neuroscience & Biobehavioral Reviews.
[55] Amisha A. Patel,et al. Retrograde optogenetic characterization of the pontospinal module of the locus coeruleus with a canine adenoviral vector , 2016, Brain Research.
[56] L. Looger,et al. A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons , 2016, Neuron.
[57] GándaraCarolina,et al. Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice. , 2017 .
[58] J. A. Carlos,et al. A historical reflection of the contributions of Cajal and Golgi to the foundations of neuroscience , 2007, Brain Research Reviews.
[59] Xiang Ma,et al. Targeting transgene to the heart and liver with AAV9 by different promoters , 2015, Clinical and experimental pharmacology & physiology.
[60] Phillip A. Richmond,et al. Prolonged Cre expression driven by the α-myosin heavy chain promoter can be cardiotoxic. , 2015, Journal of molecular and cellular cardiology.
[61] G. Feng,et al. Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP , 2000, Neuron.
[62] H. Akil,et al. Controlling signaling with a specifically designed Gi-coupled receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[63] Ilana B. Witten,et al. Recombinase-Driver Rat Lines: Tools, Techniques, and Optogenetic Application to Dopamine-Mediated Reinforcement , 2011, Neuron.
[64] Jacob G. Bernstein,et al. Optogenetic tools for analyzing the neural circuits of behavior , 2011, Trends in Cognitive Sciences.
[65] Roger A. H. Adan,et al. Combined Use of the Canine Adenovirus-2 and DREADD-Technology to Activate Specific Neural Pathways In Vivo , 2014, PloS one.
[66] HindererChristian,et al. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN , 2018 .
[67] M. Luijendijk,et al. Recombinant Adeno-Associated Virus: Efficient Transduction of the Rat VMH and Clearance from Blood , 2014, PloS one.
[68] Y. Niv,et al. Lateral Hypothalamic GABAergic Neurons Encode Reward Predictions that Are Relayed to the Ventral Tegmental Area to Regulate Learning , 2017, Current Biology.
[69] J. Lavail,et al. Retrograde Axonal Transport in the Central Nervous System , 1972, Science.
[70] V. Gradinaru,et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems , 2017, Nature Neuroscience.
[71] M. Larsson. Non-canonical heterogeneous cellular distribution and co-localization of CaMKIIα and CaMKIIβ in the spinal superficial dorsal horn , 2017, Brain Structure and Function.
[72] Brian Zingg,et al. AAV-Mediated Anterograde Transsynaptic Tagging: Mapping Corticocollicular Input-Defined Neural Pathways for Defense Behaviors , 2017, Neuron.
[73] Rafael J. Yáñez-Muñoz,et al. Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector , 2011, Gene Therapy.
[74] David C Rowland,et al. Generation of a Synthetic Memory Trace , 2012, Science.
[75] J. Livet,et al. A technicolour approach to the connectome , 2008, Nature Reviews Neuroscience.
[76] V. Friedrich,et al. Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression , 1992, The Journal of cell biology.
[77] R. MacLaren,et al. Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina , 2016, Molecular therapy. Nucleic acids.
[78] P. Golshani,et al. Direct Reactivation of a Coherent Neocortical Memory of Context , 2014, Neuron.
[79] Ian R. Wickersham,et al. Nontoxic, double-deletion-mutant rabies viral vectors for retrograde targeting of projection neurons , 2018, Nature Neuroscience.
[80] B. Roth,et al. Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats , 2016, Neuropsychopharmacology.
[81] Liqun Luo,et al. Diversity of Transgenic Mouse Models for Selective Targeting of Midbrain Dopamine Neurons , 2015, Neuron.
[82] T. Flotte,et al. In vivo model of adeno-associated virus vector persistence and rescue , 1996, Journal of virology.
[83] M. Wessendorf,et al. Fluro-Gold: composition, and mechanism of uptake , 1991, Brain Research.
[84] Dirk Grimm,et al. Next-generation AAV vectors - don't judge a virus (only) by its cover. , 2019, Human molecular genetics.
[85] K. Kissa,et al. Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[86] M. During,et al. Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[87] Kenji F. Tanaka,et al. Hippocampal Memory Traces Are Differentially Modulated by Experience, Time, and Adult Neurogenesis , 2014, Neuron.
[88] Matt Wachowiak,et al. Transgene Expression in Target-Defined Neuron Populations Mediated by Retrograde Infection with Adeno-Associated Viral Vectors , 2013, The Journal of Neuroscience.
[89] D. Gonzalez-Dunia,et al. Production and purification of non replicative canine adenovirus type 2 derived vectors. , 2013, Journal of visualized experiments : JoVE.
[90] Karl Deisseroth,et al. Optogenetics in Neural Systems , 2011, Neuron.
[91] R. Duman,et al. Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects , 2019, Nature Communications.
[92] C. Betancur,et al. Viral vector‐mediated Cre recombinase expression in substantia nigra induces lesions of the nigrostriatal pathway associated with perturbations of dopamine‐related behaviors and hallmarks of programmed cell death , 2019, Journal of neurochemistry.
[93] Martin Sarter,et al. The paraventricular thalamus is a critical mediator of top-down control of cue-motivated behavior in rats , 2019, bioRxiv.
[94] K. Deisseroth,et al. Millisecond-timescale, genetically targeted optical control of neural activity , 2005, Nature Neuroscience.
[95] D. Pfaff,et al. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[96] Douglas R Martin,et al. In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[97] Thomas E Prisinzano,et al. Role of Ventral Subiculum in Context-Induced Relapse to Alcohol Seeking after Punishment-Imposed Abstinence , 2016, The Journal of Neuroscience.
[98] G. Silberberg,et al. A Whole-Brain Atlas of Inputs to Serotonergic Neurons of the Dorsal and Median Raphe Nuclei , 2014, Neuron.
[99] Qian-Quan Sun,et al. Distribution of CaMKIIα expression in the brain in vivo, studied by CaMKIIα-GFP mice , 2013, Brain Research.
[100] P. Reier,et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters , 1997, Gene Therapy.
[101] S. Weger,et al. Packaging of Human Chromosome 19-Specific Adeno-Associated Virus (AAV) Integration Sites in AAV Virions during AAV Wild-Type and Recombinant AAV Vector Production , 2003, Journal of Virology.
[102] Akira Niwa,et al. Direct Hematological Toxicity and Illegitimate Chromosomal Recombination Caused by the Systemic Activation of CreERT21 , 2009, The Journal of Immunology.
[103] P. Strick,et al. Rabies as a transneuronal tracer of circuits in the central nervous system , 2000, Journal of Neuroscience Methods.
[104] Wade G Regehr,et al. In Vivo Targeted Expression of Optogenetic Proteins Using Silk/AAV Films. , 2019, Journal of visualized experiments : JoVE.
[105] David J. Barker,et al. Selective Brain Distribution and Distinctive Synaptic Architecture of Dual Glutamatergic-GABAergic Neurons. , 2018, Cell reports.
[106] Adam Kepecs,et al. A Viral Receptor Complementation Strategy to Overcome CAV-2 Tropism for Efficient Retrograde Targeting of Neurons , 2018, Neuron.
[107] Douglas R Martin,et al. Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain. , 2017, Human gene therapy.
[108] J. Marth,et al. Tissue- and site-specific DNA recombination in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[109] Dietmar Schmitz,et al. Optogenetic Tools for Subcellular Applications in Neuroscience , 2017, Neuron.
[110] K. Kristensson,et al. Retrograde axonal transport of protein. , 1971, Brain research.
[111] H. Groenewegen,et al. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics , 2003, Neuroscience & Biobehavioral Reviews.
[112] Y. Ikeda,et al. Lentiviral vectors: basic to translational. , 2012, The Biochemical journal.
[113] Hannah Monyer,et al. Functional Characterization of Intrinsic Cholinergic Interneurons in the Cortex , 2007, The Journal of Neuroscience.
[114] Donald W. Pfaff,et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain , 1994, Nature Genetics.
[115] P. Reier,et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[116] W. Strohl,et al. Adeno-Associated Virus (AAV) as a Vector for Gene Therapy , 2017, BioDrugs.
[117] Kevin T. Beier,et al. Neuroanatomy goes viral! , 2015, Front. Neuroanat..
[118] J. Grieger,et al. Packaging Capacity of Adeno-Associated Virus Serotypes: Impact of Larger Genomes on Infectivity and Postentry Steps , 2005, Journal of Virology.
[119] J. Rabinowitz,et al. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[120] Ian R. Wickersham,et al. Monosynaptic Restriction of Transsynaptic Tracing from Single, Genetically Targeted Neurons , 2007, Neuron.
[121] G. Ronzitti,et al. Emerging Issues in AAV-Mediated In Vivo Gene Therapy , 2017, Molecular therapy. Methods & clinical development.
[122] Brian J. Wiltgen,et al. Cortical Representations Are Reinstated by the Hippocampus during Memory Retrieval , 2014, Neuron.
[123] Lief E. Fenno,et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety , 2011, Nature.
[124] C. Barcia,et al. Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells. , 2006, Neuron glia biology.
[125] D. Fitzpatrick,et al. Opportunities and challenges in modeling human brain disorders in transgenic primates , 2016, Nature Neuroscience.
[126] M. Weitzman,et al. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. , 1999, Human gene therapy.
[127] J. Levine,et al. Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury , 2014, Gene Therapy.
[128] Viviana Gradinaru,et al. Viral Strategies for Targeting the Central and Peripheral Nervous Systems. , 2018, Annual review of neuroscience.
[129] M. S. Chapman,et al. Structure of AAV-DJ, a retargeted gene therapy vector: cryo-electron microscopy at 4.5 Å resolution. , 2012, Structure.
[130] O. Danos,et al. Canine Adenovirus Vectors: an Alternative for Adenovirus-Mediated Gene Transfer , 2000, Journal of Virology.
[131] P. Hermonat,et al. The packaging capacity of adeno‐associated virus (AAV) and the potential for wild‐type‐plus AAV gene therapy vectors , 1997, FEBS letters.
[132] R. Klein,et al. The advent of AAV9 expands applications for brain and spinal cord gene delivery , 2012, Expert opinion on biological therapy.
[133] N. Slater,et al. Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye , 2018, Pharmaceutical Research.
[134] Karl Deisseroth,et al. Integration of optogenetics with complementary methodologies in systems neuroscience , 2017, Nature Reviews Neuroscience.
[135] R. Samulski,et al. Selective and rapid uptake of adeno-associated virus type 2 in brain. , 1998, Human gene therapy.
[136] S. Vrati,et al. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls , 2015, Expert opinion on biological therapy.
[137] S. Salinas,et al. An Update on Canine Adenovirus Type 2 and Its Vectors , 2010, Viruses.
[138] Floris G. Wouterlood,et al. A half century of experimental neuroanatomical tracing , 2011, Journal of Chemical Neuroanatomy.
[139] Douglas R Martin,et al. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[140] Bert Sakmann,et al. The extracellular patch clamp: A method for resolving currents through individual open channels in biological membranes , 1978, Pflügers Archiv.
[141] O. Isacson,et al. A high-efficiency synthetic promoter that drives transgene expression selectively in noradrenergic neurons. , 2001, Human gene therapy.
[142] Sripriya Ravindra Kumar,et al. Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types , 2020, Nature Methods.
[143] Dominik Fröhlich,et al. Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes , 2016, Front. Mol. Neurosci..
[144] Shawn R. Olsen,et al. Characterization of Channelrhodopsin and Archaerhodopsin in Cholinergic Neurons of Cre-Lox Transgenic Mice , 2016, PloS one.
[145] Haiyan Zhou,et al. The progress of AAV-mediated gene therapy in neuromuscular disorders , 2018, Expert opinion on biological therapy.
[146] R. Mandel,et al. Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[147] L. Vandenberghe,et al. Novel adeno-associated viral vectors for retinal gene therapy , 2011, Gene Therapy.
[148] R. Neve,et al. Enhancing Depression Mechanisms in Midbrain Dopamine Neurons Achieves Homeostatic Resilience , 2014, Science.
[149] A. Berns,et al. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[150] P. Fan,et al. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. , 1996, Human gene therapy.
[151] S. Sternson,et al. A FLEX Switch Targets Channelrhodopsin-2 to Multiple Cell Types for Imaging and Long-Range Circuit Mapping , 2008, The Journal of Neuroscience.
[152] D. Schaffer,et al. Adeno-associated virus (AAV) vectors in cancer gene therapy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[153] R. Linden,et al. The recombination signals for adeno-associated virus site-specific integration. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[154] R. W. Draft,et al. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system , 2007, Nature.
[155] V. Bigl,et al. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. , 1996, Progress in brain research.
[156] T. Robbins,et al. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry , 2002, Psychopharmacology.
[158] Fumitaka Osakada,et al. Design and generation of recombinant rabies virus vectors , 2013, Nature Protocols.
[159] G. Breese,et al. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector , 1996, Brain Research.
[160] Edward M. Callaway,et al. Genetic Dissection of Neural Circuits: A Decade of Progress. , 2018, Neuron.
[161] R. Samulski,et al. Global CNS Gene Delivery and Evasion of Anti-AAV Neutralizing Antibodies by Intrathecal AAV Administration in Non-Human Primates , 2012, Gene Therapy.
[162] S. Rumpel,et al. Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain , 2013, PloS one.
[163] K. Deisseroth,et al. Sustained Attentional States Require Distinct Temporal Involvement of the Dorsal and Ventral Medial Prefrontal Cortex , 2016, Front. Neural Circuits.
[164] J. Wolfe,et al. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[165] R. Hoess,et al. Bacteriophage P1 site-specific recombination. Purification and properties of the Cre recombinase protein. , 1984, The Journal of biological chemistry.
[166] R. Fässler,et al. Cre recombinase induces DNA damage and tetraploidy in the absence of LoxP sites , 2014, Cell cycle.
[167] H. Mansvelder,et al. An automated home-cage-based 5-choice serial reaction time task for rapid assessment of attention and impulsivity in rats , 2019, Psychopharmacology.
[168] B. Roth,et al. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand , 2007, Proceedings of the National Academy of Sciences.
[169] Feng Zhang,et al. Multimodal fast optical interrogation of neural circuitry , 2007, Nature.
[170] C. Cepko,et al. AAV cis-regulatory sequences are correlated with ocular toxicity , 2019, Proceedings of the National Academy of Sciences.
[171] D. Mccarty. Self-complementary AAV vectors; advances and applications. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[172] T. Robbins,et al. Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task , 2002, Psychopharmacology.
[173] Liqun Luo,et al. Circuit Architecture of VTA Dopamine Neurons Revealed by Systematic Input-Output Mapping , 2015, Cell.
[174] A. Messing,et al. GFAP promoter directs astrocyte-specific expression in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[175] Edgar A Ycu,et al. Modular organization of the brainstem noradrenaline system coordinates opposing learning states , 2017, Nature Neuroscience.
[176] M. Levings,et al. Ectopic germline recombination activity of the widely used Foxp3‐YFP‐Cre mouse: a case report , 2019, Immunology.
[177] Dominik Fröhlich,et al. Glial Promoter Selectivity following AAV-Delivery to the Immature Brain , 2013, PloS one.
[178] James M. Wilson,et al. The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. , 2011, The Journal of clinical investigation.
[179] Erin J Campbell,et al. The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats , 2018, British journal of pharmacology.
[180] B. Roska,et al. CREATEd viruses go global , 2017, Nature Neuroscience.
[181] W. Wold,et al. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. , 2014, Current gene therapy.
[182] Edward M. Callaway,et al. Short Promoters in Viral Vectors Drive Selective Expression in Mammalian Inhibitory Neurons, but do not Restrict Activity to Specific Inhibitory Cell-Types , 2009, Frontiers in neural circuits.
[183] Mika Ito,et al. Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease. , 2017, Human gene therapy. Clinical development.
[184] L. V. von Segesser,et al. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. , 2003, International journal of cardiology.
[185] Michael J. Castle,et al. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids. , 2016, Methods in molecular biology.
[186] A. Verkman,et al. New drug targets for cholera therapy. , 2005, Trends in pharmacological sciences.
[187] K. Rapti,et al. Effectiveness of gene delivery systems for pluripotent and differentiated cells , 2015, Molecular therapy. Methods & clinical development.
[188] R. Palmiter,et al. Detecting and Avoiding Problems When Using the Cre-lox System. , 2018, Trends in genetics : TIG.
[189] Praneeth Namburi,et al. Divergent Routing of Positive and Negative Information from the Amygdala during Memory Retrieval , 2016, Neuron.